Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Enliven Therapeutics, Inc
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-08-24
Sale
2023-08-28
4:20 pm
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
440,000$16$7,040,000887,507
(Indirect)
View
2023-02-23
Purchase
2023-02-27
5:14 pm
Enliven Therapeutics Inc.ELVNCOMMODORE CAPITAL LP
10% Owner
622$22.07$13,7232,178,531
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-05-17
Exercise
2023-05-19
4:19 pm
N/A
2032-06-01
Enliven Therapeutics Inc.ELVNORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
10% Owner
2,125$08,951,463
(Indirect)
View
2023-05-17
Exercise
2023-05-19
4:19 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
10% Owner
2,125$4.288,951,463
(Indirect)
View
2023-05-17
Exercise
2023-05-19
4:12 pm
N/A
2032-06-01
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
2,125$08,951,463
(Indirect)
View
2023-05-17
Exercise
2023-05-19
4:12 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
2,125$4.288,951,463
(Indirect)
View
2023-04-04
Option Award
2023-04-06
8:34 pm
N/A
2033-04-04
Enliven Therapeutics Inc.ELVNPatel Anish
Chief Operating Officer
206,000$0206,000
(Direct)
View
2023-04-04
Option Award
2023-04-06
8:33 pm
N/A
2033-04-04
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
Chief Scientific Officer
206,000$0206,000
(Direct)
View
2023-04-04
Option Award
2023-04-06
8:32 pm
N/A
2033-04-04
Enliven Therapeutics Inc.ELVNHohl Benjamin
Chief Financial Officer
206,000$0206,000
(Direct)
View
2023-04-04
Option Award
2023-04-06
8:32 pm
N/A
2033-04-04
Enliven Therapeutics Inc.ELVNCollins Helen Louise
Chief Medical Officer
206,000$0206,000
(Direct)
View
2023-04-04
Option Award
2023-04-06
8:30 pm
N/A
2033-04-04
Enliven Therapeutics Inc.ELVNKintz Samuel
President and CEO
452,000$0452,000
(Direct)
View
2023-02-23
Option Award
2023-04-06
8:22 pm
N/A
2033-02-23
Enliven Therapeutics Inc.ELVNSchwab Andrew J.
Director
10% Owner
27,567$027,567
(Direct)
View
2023-02-23
Option Award
2023-04-06
8:20 pm
N/A
2033-02-23
Enliven Therapeutics Inc.ELVNPhillips Andrew John
Director
27,567$027,567
(Direct)
View
2023-02-23
Option Award
2023-04-06
8:19 pm
N/A
2033-02-23
Enliven Therapeutics Inc.ELVNHeyman Richard A.
Director
34,458$034,458
(Direct)
View
2023-02-23
Option Award
2023-04-06
8:18 pm
N/A
2033-02-23
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
27,567$027,567
(Direct)
View
2023-02-23
Option Award
2023-04-06
8:17 pm
N/A
2033-02-23
Enliven Therapeutics Inc.ELVNDerynck Mika K
Director
27,567$027,567
(Direct)
View
2023-02-23
Option Award
2023-04-06
8:16 pm
N/A
2033-02-23
Enliven Therapeutics Inc.ELVNBauer Jake
Director
27,567$027,567
(Direct)
View
2023-02-23
Option Award
2023-04-06
8:15 pm
N/A
2033-02-23
Enliven Therapeutics Inc.ELVNBallal Rahul D.
Director
27,567$027,567
(Direct)
View

Ownership
2023-03-06
5:18 pm
N/A
N/A
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
10% Owner
0$05,798,475
(Indirect)
View
2023-02-23
Option Award
2023-02-27
9:55 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNSchwab Andrew J.
Director
5,798,475$0960,383
(Indirect)
View
2023-02-23
Option Award
2023-02-27
9:54 pm
N/A
2032-08-12
Enliven Therapeutics Inc.ELVNHeyman Richard A.
Director
239,056$0201,649
(Direct)
View
2023-02-23
Option Award
2023-02-27
9:53 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
7,899,572$0288,114
(Indirect)
View
2023-02-23
Option Award
2023-02-27
9:51 pm
N/A
2032-08-12
Enliven Therapeutics Inc.ELVNBauer Jake
Director
105,078$0105,078
(Direct)
View
2023-02-23
Option Award
2023-02-27
9:43 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNDerynck Mika K
Director
87,373$087,373
(Direct)
View
2023-02-23
Option Award
2023-02-27
9:35 pm
N/A
2030-06-15
Enliven Therapeutics Inc.ELVNPatel Anish
Chief Operating Officer
519,963$0519,963
(Direct)
View
2023-02-23
Option Award
2023-02-27
9:34 pm
N/A
2030-06-15
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
Chief Scientific Officer
1,550,116$01,550,116
(Direct)
View
2023-02-23
Option Award
2023-02-27
9:33 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
Chief Financial Officer
262,120$0262,120
(Direct)
View
2023-02-23
Option Award
2023-02-27
9:33 pm
N/A
2030-06-15
Enliven Therapeutics Inc.ELVNKintz Samuel
President and CEO
1,924,969$0837,444
(Direct)
View
2023-02-23
Option Award
2023-02-27
9:32 pm
N/A
2031-06-17
Enliven Therapeutics Inc.ELVNCollins Helen Louise
Chief Medical Officer
287,084$0287,084
(Direct)
View
2023-02-23
Option Award
2023-02-27
8:30 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
10% Owner
7,899,572$0288,114
(Indirect)
View
2023-02-23
Other
2023-02-27
5:14 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNCOMMODORE CAPITAL LP
10% Owner
729,891$02,178,531
(Indirect)
View
Goto 0, 1, 2, 3, Next